+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast 2025-2030- Product Image
Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast 2025-2030- Product Image
Sale

Human Embryonic Stem Cells Market by Product, Application, End User, Indication, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674543
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human embryonic stem cells market is evolving at pace, shaped by intersecting advances in science, technology, and regulation. Senior executives seeking actionable intelligence for investment and expansion strategies in this domain require a comprehensive analysis grounded in robust market insights.

Market Snapshot: Human Embryonic Stem Cells Market Overview

The Human Embryonic Stem Cells Market grew from USD 920.43 million in 2024 to USD 1.00 billion in 2025. It is expected to continue growing at a CAGR of 9.08%, reaching USD 1.55 billion by 2030. Driven by developments in cell biology, manufacturing scale-up, and regulatory support, the market’s trajectory reflects an expanding range of clinical and commercial applications. Regional variations, regulatory frameworks, and enhanced funding have collectively fostered an environment conducive to innovation, enabling stakeholders to capitalize on new therapeutic, diagnostic, and research opportunities.

Scope & Segmentation: Comprehensive Coverage of the Embryonic Stem Cell Value Chain

  • Product Categories: Accessories and consumables, differentiation reagents including growth factor kits and small molecule reagents, culture media (serum-based and serum-free), human embryonic stem cell lines (clinical grade, research grade), serums, and growth factors.
  • Application Areas: Encompasses basic research, clinical research, drug discovery and development (with target and toxicity screening), regenerative medicine (cell therapy, tissue engineering), and toxicology testing.
  • End User Segments: Academic and research institutes, contract research organizations, hospitals and clinics, pharmaceutical and biotechnology companies.
  • Indication Focus: Cardiovascular disorders (including heart failure and ischemic heart disease), diabetes (type 1 and type 2), neurological disorders (such as Alzheimer’s and Parkinson’s), orthopedic disorders (bone regeneration, cartilage repair).
  • Technology Platforms: Allogeneic therapies (matched donor, off-the-shelf therapies), autologous human embryonic stem cell approaches.
  • Geographical Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and other key countries), Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Competitive Landscape: Profiles leading companies such as Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, STEMCELL Technologies, Bio-Techne, Corning, Miltenyi Biotec, Fujifilm Holdings, and American Type Culture Collection.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Human embryonic stem cells remain a foundation for regenerative therapies, with innovation in genome editing, bioprocessing, and media optimization increasing reproducibility and application specificity across research and clinical pipelines.
  • Adaptive regulatory environments in select regions enable faster clinical translation, while others necessitate regionally nuanced compliance strategies to balance research acceleration with oversight requirements.
  • Segment diversification—across product, application, and end-user categories—supports a spectrum of solutions from basic research to commercialized therapeutics, increasing opportunities for partnership and market penetration.
  • Collaborative models among academic, clinical, and commercial entities drive progress by pooling capabilities, mitigating operational bottlenecks, and facilitating the scalable manufacturing of stem cell derivatives.
  • Localized investment in infrastructure and expanded funding in high-growth markets are fueling capacity building, resulting in accelerating adoption and increased regional competitiveness.
  • Allogeneic and autologous technologies present unique advantages, with off-the-shelf therapies offering broader reach and personalized approaches serving niche clinical needs.

Tariff Impact: Navigating U.S. Policy Adjustments

Recent U.S. tariff changes have increased cost pressures on raw material imports, laboratory equipment, and critical reagents for embryonic stem cell operations. Extended customs procedures and compliance measures have led to longer lead times, requiring proactive sourcing and supply chain management. The tariff climate is reshaping partnership models, supplier relationships, and investment decisions, with greater emphasis on local production, risk diversification, and resilient procurement frameworks to ensure research continuity and commercial scale-up.

Human Embryonic Stem Cells Market: Methodology & Data Sources

This report is grounded in a blend of primary and secondary research. Experts conducted interviews with scientists, regulatory authorities, and industry leaders, and measured insights through structured surveys of laboratory leadership and procurement professionals. Peer-reviewed literature, regulatory filings, and patent analyses formed the backbone for secondary validation, while advanced analytical frameworks including SWOT, PESTEL, and scenario modeling provided depth and consistency.

Why This Report Matters: Decision-Grade, Operational Intelligence

  • Supports executive decision-making by clarifying market segments, regional dynamics, and technology pathways driving the stem cell industry forward.
  • Enables risk management and opportunity identification through thorough analysis of regulatory shifts, tariff effects, and evolving supply chain demands.
  • Highlights actionable intelligence for investment, partnership, and expansion—equipping leaders to allocate resources efficiently in a complex global market.

Conclusion

The human embryonic stem cells market presents a diverse landscape shaped by technological advancement, policy shifts, and collaborative initiatives. This report equips decision-makers to navigate evolving market dynamics and seize new growth opportunities with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in gene editing techniques enhancing human embryonic stem cell therapies
5.2. Regulatory pathway harmonization and its impact on global human embryonic stem cell approvals
5.3. Development of xeno-free culture media for large-scale embryonic stem cell manufacturing
5.4. Strategic collaborations between biopharma and academia for hESC-based regenerative medicine
5.5. Emerging applications of human embryonic stem cells in neurological disorder modeling
5.6. Commercialization challenges of hESC-derived cardiomyocytes for cardiovascular treatments
5.7. Ethical debate evolution shaping investor confidence in human embryonic stem cell startups
5.8. Role of 3D bioprinting combined with human embryonic stem cells in organogenesis research
5.9. Market penetration strategies for hESC-based therapies in emerging Asia-Pacific regions
5.10. Impact of CRISPR-Cas9 safety profiling on translation of embryonic stem cell therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Embryonic Stem Cells Market, by Product
8.1. Introduction
8.2. Accessories And Consumables
8.2.1. Accessories
8.2.2. Consumables
8.3. Differentiation Reagents
8.3.1. Growth Factor Kits
8.3.2. Small Molecule Reagents
8.4. Human Embryonic Stem Cell Culture Media
8.4.1. Serum Based
8.4.2. Serum Free
8.5. Human Embryonic Stem Cell Lines
8.5.1. Clinical Grade
8.5.2. Research Grade
8.6. Serums And Growth Factors
8.6.1. Growth Factors
8.6.2. Serum
9. Human Embryonic Stem Cells Market, by Application
9.1. Introduction
9.2. Basic Research
9.3. Clinical Research
9.4. Drug Discovery And Development
9.4.1. Target Screening
9.4.2. Toxicity Screening
9.5. Regenerative Medicine
9.5.1. Cell Therapy
9.5.2. Tissue Engineering
9.6. Toxicology Testing
10. Human Embryonic Stem Cells Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals And Clinics
10.5. Pharmaceutical And Biotechnology Companies
10.5.1. Biotechnology Companies
10.5.2. Pharmaceutical Companies
11. Human Embryonic Stem Cells Market, by Indication
11.1. Introduction
11.2. Cardiovascular Disorders
11.2.1. Heart Failure
11.2.2. Ischemic Heart Disease
11.3. Diabetes
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.4. Neurological Disorders
11.4.1. Alzheimers Disease
11.4.2. Parkinsons Disease
11.5. Orthopedic Disorders
11.5.1. Bone Regeneration
11.5.2. Cartilage Repair
12. Human Embryonic Stem Cells Market, by Technology
12.1. Introduction
12.2. Allogeneic Hesc
12.2.1. Matched Donor Therapies
12.2.2. Off The Shelf Therapies
12.3. Autologous Hesc
13. Americas Human Embryonic Stem Cells Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Embryonic Stem Cells Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Embryonic Stem Cells Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Lonza Group Ltd.
16.3.5. STEMCELL Technologies Inc.
16.3.6. Bio-Techne Corporation
16.3.7. Corning Incorporated
16.3.8. Miltenyi Biotec GmbH
16.3.9. Fujifilm Holdings Corporation
16.3.10. American Type Culture Collection
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN EMBRYONIC STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN EMBRYONIC STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN EMBRYONIC STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN EMBRYONIC STEM CELLS MARKET: RESEARCHAI
FIGURE 26. HUMAN EMBRYONIC STEM CELLS MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN EMBRYONIC STEM CELLS MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN EMBRYONIC STEM CELLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN EMBRYONIC STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTOR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTOR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SMALL MOLECULE REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SMALL MOLECULE REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TARGET SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TARGET SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICITY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICITY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY MATCHED DONOR THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY MATCHED DONOR THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY OFF THE SHELF THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY OFF THE SHELF THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS HESC, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY AUTOLOGOUS HESC, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 213. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 216. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 217. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 218. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 219. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 220. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 221. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 222. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 223. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 224. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2025-2030 (USD MILLION)
TABLE 225. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 228. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 229. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 230. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 231. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 234. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 235. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 238. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 239. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 240. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 241. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 242. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 243. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 244. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 245. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2024 (USD MILLION)
TABLE 248. CANADA HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2025-2030 (USD MILLION)
TABLE 249. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 256. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 257. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 258. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 264. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 265. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 270. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 271. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2018-2024 (USD MILLION)
TABLE 284. MEXICO HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ALLOGENEIC HESC, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY DIFFERENTIATION REAGENTS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL CULTURE MEDIA, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL LINES, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL HUMAN EMBRYONIC STEM CELLS MARKET SIZE, BY SERUMS AND GROWTH FACTORS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL HUMAN EMBRYONIC STEM CELLS

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group Ltd.
  • STEMCELL Technologies Inc.
  • Bio-Techne Corporation
  • Corning Incorporated
  • Miltenyi Biotec GmbH
  • Fujifilm Holdings Corporation
  • American Type Culture Collection

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.55 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Human Embryonic Stem Cells Market by Cell Line Type, by Application, by End-User, and By Region - Product Image

Human Embryonic Stem Cells Market by Cell Line Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report - Product Image

Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Human Embryonic Stem Cells Market Report 2025 - Product Image

Human Embryonic Stem Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Stem Cells Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine), Technology, Therapy, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From

About the Embryonic Stem Cell Market

The Embryonic Stem Cell (ESC) market is a subset of the larger stem cell market. ESCs are derived from embryos and are pluripotent, meaning they can differentiate into any cell type in the body. They are used in research to study the development of cells and tissues, and in regenerative medicine to replace damaged or diseased cells. ESCs are also used in drug discovery and development, as they can be used to test the safety and efficacy of new drugs. The ESC market is highly regulated, as the use of embryos is controversial. Regulations vary by country, and some countries have banned the use of ESCs altogether. Despite this, the ESC market is growing, driven by advances in stem cell research and the potential for regenerative medicine. Companies in the ESC market include Cellular Dynamics International, Pluristem Therapeutics, and Stem Cell Therapeutics. These companies are involved in the research, development, and commercialization of ESCs for therapeutic and research applications. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.